POSTER SESSION III & CONTINENTAL BREAKFAST

PS 3-17

ARE MECHANICAL TURK WORKER SAMPLES REPRESENTATIVE OF HEALTH STATUS AND HEALTH BEHAVIORS IN THE U.S.?

Davene R. Wright, PhD¹, Kelly Walters, BS, MPH² and Dimitri Christakis, MD, MPH², (1)University of Washington, Seattle, WA, (2)Seattle Children's Research Institute, Seattle, WA

PS 3-1

HOW OFTEN DO COST-EFFECTIVENESS ANALYSES INCORPORATE PATIENT-LEVEL HETEROGENEITY? A REVIEW OF THE LITERATURE

Tara Lavelle, PhD¹, David M. Kent, MD, MSc², Christine Lundquist, MPH², Teja Thorat, M.Sc., MPH², Joshua T. Cohen, PhD², John B. Wong, MD², Natalia Olchanski, MS² and Peter J. Neumann, Sc.D.², (1)Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, (2)Tufts Medical Center, Boston, MA

PS 3-2

COST-EFFECTIVENESS OF REPLACING OPEN LIVER RESECTION WITH LAPAROSCOPIC LIVER RESECTION FOR PATIENTS WITH COLORECTAL LIVER METASTASES. ANALYSES PERFORMED ALONGSIDE A RANDOMIZED CONTROLLED TRIAL: THE OSLO-COMET STUDY

Gudrun Maria Waaler Bjørnelv, M.Phil.¹, Åsmund Avdem Fretland, MD¹, Bjørn Edwin, PhD¹, Ronny Kristiansen¹, Linda Engvik¹, Vinod Mishra, PhD², Jack Gunnar Andersen² and Eline Aas, PhD³, (1)Oslo university hospital, The Intervention Centre, Oslo, Norway, (2)Oslo university hospital, Oslo, Norway, (3)Department of Health Management and Health Economics, University of Oslo, Oslo, Norway

PS 3-3

A COST-EFFECTIVENESS EVALUATION OF IBRUTINIB FOR PATIENTS WITH RELAPSED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) IN BRITISH COLUMBIA, CANADA

Sarah Costa, MSc¹, Joseph M. Connors, MD., FRCPC², Ian Cromwell, MSc¹, David W. Scott, MBChB, PhD², Stuart J. Peacock, D.Phil.¹ and Dean A. Regier, PhD³, (1)Canadian Centre for Applied Research in Cancer Control, Vancouver, BC, Canada, (2)Centre for Lymphoid Cancer, BC Cancer Agency, Vancouver, BC, Canada, (3)Canadian Centre for Applied Research in Cancer Control, BC Cancer Agency, Vancouver, BC, Canada

PS 3-4

THE HEALTH-LOSS BURDEN OF OSTEOARTHRITIS IN NEW ZEALAND: RESULTS FROM A NEW COMPUTER-SIMULATION MODEL

Ross Wilson¹, J Haxby Abbott¹, Tony Blakely², Giorgi Kvizhinadze² and Elena Losina, PhD³, (1)University of Otago, Dunedin, New Zealand, (2)University of Otago, Wellington, New Zealand, (3)Brigham and Women's Hospital, Boston, MA

PS 3-6

A SYSTEMATIC REVIEW OF RESOURCE USE AND HEALTH OUTCOMES MEASUREMENT TOOLS IN CLINICAL TRIALS FOR DEMENTIA OR COGNITIVE IMPAIRMENT INTERVENTIONS

Fan Yang, PhD¹, Piers Dawes, PhD², Iracema Leroi, PhD³ and Brenda Gannon, PhD¹, (1)Manchester Centre for Health Economics, University of Manchester, Manchester, United Kingdom, (2)Manchester Centre for Audiology and Deafness, University of Manchester, Manchester, United Kingdom, (3)Manchester Mental Health and Social Care Trust Institute of Brain, University of Manchester, Manchester, United Kingdom

PS 3-7

EVALUATION OF CHRONIC DISEASE PREVENTION INTERVENTIONS WITH A DYNAMIC SIMULATION MODEL

Nisa Onsel, MSc, Yaman Barlas, PhD and Gonenc Yucel, PhD, Bogazici University, Istanbul, Turkey

PS 3-8

CHALLENGES IN THE DIAGNOSIS OF SOFT TISSUE SARCOMA: A COMPARISON OF PRE-DIAGNOSIS CONDITIONS AND HEALTH CARE RESOURCE USE BETWEEN KNOWN SOFT TISSUE SARCOMA PATIENTS AND MATCHED CONTROLS IN CLAIMS DATA

Yajun Zhu, MS¹, Yun Fang, MS², Steven Nicol, MD¹, Julie Beyrer, MPH, MTSC¹ and Lisa M. Hess, PhD³, (1)Eli Lilly and Company, Indianapolis, IN, (2)inVentiv Health Clinical, Burlington, MA, (3)Eli Lilly and Co, Indianapolis, IN

PS 3-9

ECONOMIC EVALUATION OF DISINVESTMENT IN HYDROXYETHYL STARCHES FOR CARDIAC SURGERY

Ava John-Baptiste, PhD¹, Yuan Qi, BSc², Philip Jones, MD, MSc³, Davy Cheng, MD, MSc³ and Janet E. Martin, PharmD, MSc(HTA&M)¹, (1)Centre for Medical Evidence, Decision Integrity & Clinical Impact (MEDICI), Western University, London, ON, Canada, (2)Schulich School of Medicine and Dentistry, Western University, London, ON, Canada, (3)Department of Anesthesia & Perioperative Medicine, Western University, London, ON, Canada

PS 3-10

FROM UNCERTAINTY TO ACTION IN PEDIATRIC PRECISION MEDICINE: GENERATING EVIDENCE OF THE COST-EFFECTIVENESS OF CLINICAL EXOME AND GENOME SEQUENCING IN AUTISM SPECTRUM DISORDER

Kate Tsiplova, MSc¹, Richard M. Zur, PhD¹, Christian R. Marshall, PhD¹, D. James Stavropoulos, PhD¹, Sergio Pereira, PhD¹, Daniele Merico, PhD¹, Edwin J. Young, PhD¹, Stephen W. Scherer, PhD¹ and Wendy J. Ungar, MSc, PhD², (1)Toronto, ON, Canada, (2)The Hospital for Sick Children Peter Gilgan Centre for Research and Learning, Toronto, ON, Canada

PS 3-11

AN OVERVIEW OF COST-EFFECTIVENESS OF COMMUNITY-BASED INTERVENTIONS FOR CONTROLLING HIGH BLOOD PRESSURE

Donglan Zhang, PhD, MS, Department of health policy and management, University of Georgia, Athens, GA, Heesoo Joo, PhD, US Centers for Disease Control and Prevention, Atlanta, GA and Guijing Wang, phd, cdc, atlanta, GA

PS 3-12

ECONOMIC ANALYSIS OF ORAL ANTICOAGULANTS IN THE PREVENTION OF VASCULAR EVENTS IN MEDICARE PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION

Michele Wilson¹, Jonathan Lim², Pranav Ghandhi², Cheng Wang², Stephen Sander², Cheryl McDade¹ and Stephanie Earnshaw¹, (1)RTI Health Solutions, Research Triangle Park, NC, (2)Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT

PS 3-14

BALANCE SHEET APPROACH TO FINANCIAL DEBT AND ASSETS IN CANCER SURVIVORS

Mateo Banegas, PhD¹, Diarmuid Coughlan, PhD MSc.² and Maryam Doroudi, PhD MPH², (1)Kaiser Permanente Center for Health Research, Portland, OR, (2)National Cancer Institute, Bethesda, MD

PS 3-15

EVALUATING COLORECTAL CANCER SCREENING OPTIONS FOR CANADA USING ONCOSIM

Andrew Coldman, Ph.D¹, Michael Wolfson, Ph.D², William Flanagan, B.M.³, Claude Nadeau, Ph.D³, Cindy Gauvreau, PhD⁴, Saima Memon, M.B.B.S, MPH⁴, Anthony B. Miller, MD, FRCP, (C), FFPH, FACE⁵ and Craig Earle, MD, MSc, FRCP(C)⁶, (1)BC Cancer Research Centre, Vancouver, BC, Canada, (2)University of Ottawa, Ottawa, ON, Canada, (3)Statistics Canada, Ottawa, ON, Canada, (4)Canadian Partnership Against Cancer, Toronto, ON, Canada, (5)University of Toronto, Toronto, ON, Canada, (6)Cancer Care Ontario and the Ontario Institute for Cancer Research and Institute for Clinical Evaluative Sciences, Toronto, ON, Canada

PS 3-18

DE-IMPLEMENTING CURATIVE THERAPY IN LOW-RISK PROSTATE CANCER: PRELIMINARY EVIDENCE OF UROLOGISTS' UNLEARNING

Shellie Ellis, MA, PhD¹, Kim Kimminau, PhD², Emily Jones, M.A.³, Brantley Thrasher, MD¹ and Trisha Crutchfield, MHA, MSIS⁴, (1)University of Kansas School of Medicine, Kansas City, KS, (2)Univeristy of Kansas School of Medicine, Kansas City, KS, (3)University of Kansas, Kansas City, KS, (4)UNC Center for Health Promotion and DIsease Prevention, The University of North Carolina at Chapel Hill, Chapel Hill, NC

PS 3-19

Katharine Rendle, PhD, MPH, MSW¹, Samantha Quaife, MSc² and Sarah Kobrin, PhD, MPH¹, (1)National Cancer Institute, Bethesda, MD, (2)University College London, London, United Kingdom

PS 3-20

A DECISION SUPPORT INTERVENTION TO INCREASE PARTICIPATION IN BREAST CANCER CLINICAL TRIALS

Amy Leader, DrPH, MPH¹, Laura Austin, MD¹, Tiffany Avery, MD, MPH², Anna Quinn, MPH¹, Anett Petrich, RN, BSN¹, Sarah Hegarty, MPhil¹, Russell Schilder, MD¹, Massimo Cristofanilli, MD³, Prudence Dalrymple, PhD, MS⁴, Lisl Zach, PhD, MBA, MS⁵ and Ronald Myers, DSW, PhD¹, (1)Thomas Jefferson University, Philadelphia, PA, (2)Wake Forest Baptist Medical Center, Winston Salem, NC, (3)Northwestern University, Robert H Lurie Cancer Center, Chicago, IL, (4)Drexel University College of Computing and Informatics, Philadelphia, PA, (5)Philadelphia, PA

PS 3-21

ACCEPTABILITY AND EFFICACY OF A VIDEO-BASED PATIENT DECISION AID ABOUT LUNG CANCER SCREENING WITH LOW-DOSE COMPUTED TOMOGRAPHY

Andrea P. Hempstead, Viola B. Leal, MPH, Vincent F. Richards, Lisa M. Lowenstein, PhD, MPH and Robert J. Volk, PhD, The University of Texas MD Anderson Cancer Center, Houston, TX

PS 3-22

INFORMATION NEEDS FOR OLDER WOMEN WITH EARLY STAGE BREAST CANCER WHEN MAKING RADIOTHERAPY DECISIONS

Shi-Yi Wang, MD, PhD¹, Gabrielle Kelly, PhD², Liana Fraenkel, MD, MPH³ and Cary P. Gross, MD¹, (1)Yale Cancer Center, New Haven, CT, (2)Yale School of Public Health, New Haven, CT, (3)Yale University, West Haven, CT

PS 3-23

RESPONSIVENESS OF A BRIEF MEASURE OF SMOKERS' KNOWLEDGE OF LUNG CANCER SCREENING WITH LOW-DOSE COMPUTED TOMOGRAPHY

Lisa M. Lowenstein, PhD, MPH, Andrea P. Hempstead, Vincent F. Richards, Viola B. Leal, MPH, Ashley J. Housten and Robert J. Volk, PhD, The University of Texas MD Anderson Cancer Center, Houston, TX

PS 3-24

PATIENT EXPECTATIONS FROM TREATMENT OF INCURABLE METASTATIC PROSTATE CANCER

Alicia Morgans, MD, MPH¹, Liping Du, PhD¹, Ivy Ahmed, MPH, MCHES² and David Penson, M.D.³, (1)Vanderbilt University Medical Center, Nashville, TN, (2)ZERO: The End of Prostate Cancer, Alexandria, VA, (3)Vanderbilt University, Nashville, TN

PS 3-25

DISCLOSING THE UNCERTAINTY ASSOCIATED WITH PROGNOSTIC ESTIMATES IN BREAST CANCER: CURRENT PRACTICES AND PATIENTS' PERCEPTIONS OF UNCERTAINTY

Ellen Engelhardt, Msc¹, Arwen H. Pieterse, PhD¹, Ellen MA Smets, PhD², Paul K. J. Han, MD, MA, MPH³, Johanneke Portielje, MD, PhD⁴, Judith R. Kroep, MD PhD¹, J. (Hanneke) CJM de Haes, PhD² and Anne M. Stiggelbout, PhD¹, (1)Leiden University Medical Center, Leiden, Netherlands, (2)Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands, (3)Center for Outcomes Research, Maine Medical Center Research Institute, Portland, ME, (4)Haga Ziekenuis, The Hague, Netherlands

PS 3-26

AN E-LEARNING MODULE FOR SHARED DECISION MAKING WITH OLDER CANCER PATIENTS: IMPROVEMENT OF ONCOLOGISTS' SELF-REPORTED COGNITIONS AND BEHAVIOR

Fania R. Gärtner, PhD, Arwen H. Pieterse, PhD, Monique C.M. Baas-Thijssen, RN and Anne M. Stiggelbout, PhD, Leiden University Medical Center, Leiden, Netherlands

PS 3-27

EFFECT OF A DECISION AID VS. NCI WEBSITE ON LUNG CANCER SCREENING DECISIONS AND BEHAVIOR

Margaret M. Byrne, PhD¹, Stacey Tannenbaum, PhD², Cari Eckman, MPH¹, Stephanie Maestri, MPH¹, Kory Brinker, MPH³ and Jamie Studts, PhD³, (1)University of Miami Miller School of Medicine, Miami, FL, (2)University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center, Miami, FL, (3)University of Kentucky, Lexington, KY

PS 3-28

IMPROVING KNOWLEDGE ABOUT LUNG CANCER SCREENING: EFFECT OF A DECISION AID VS. NCI WEBSITE

Margaret M. Byrne, PhD¹, Kory Brinker, MPH², Cari Eckman, MPH¹, Stacey Tannenbaum, PhD³, Stephanie Maestri, MPH¹ and Jamie Studts, PhD², (1)University of Miami Miller School of Medicine, Miami, FL, (2)University of Kentucky, Lexington, KY, (3)University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center, Miami, FL

PS 3-29

COMMUNICATION OF QUANTITATIVE INFORMATION AND UNCERTAINTY IN THE BREAST CANCER TREATMENT CONSULTATION

Marilyn Schapira, MD, MPH¹, Kathlyn Fletcher, MD, MA², Pamela Ganschow, MD³, Elizabeth Jacobs, MD⁴, Cynthia M. Walker, Ph.D.⁵, Denisse Gil³, Alicia Smallwood², Courtney Okwara⁶, Esther Nivasch, BA⁷, Arhshia Faghri⁸ and Joan Neuner, MD², (1)University of Pennsylvania, Philadelphia, PA, (2)Milwaukee, WI, (3)John H. Stroger Hospital, Chicago, IL, (4)Madison, WI, (5)University of Wisconsin, Milwaukee, WI, (6)Harvard University, Cambridge, MA, (7)Division of Gynecologic Oncology, University of Pennsylvania, Philadelphia, PA, (8)Philadelphia, PA

PS 3-30

DEVELOPMENT OF A DECISION SUPPORT AID FOR GOALS OF CARE CONVERSATION FOR HOSPITALIZED PATIENTS WITH CANCER

Marina George, MD, Lisa Stone, MPH, Karen Stepan, RN, MPH, Colleen Gallagher, PhD, Jessica Moore, DHCE, MA, Susan Gaeta, MD, Margaret Meyer, MSW, MBA, Ahmed Elsayem, MD, Robert J. Volk and Donna Zhukovsky, MD, The University of Texas MD Anderson Cancer Center, Houston, TX

PS 3-31

PATIENT SELF-ADVOCACY IN DECISION MAKING RELATED TO POST-TREATMENT SURVEILLANCE FOR COLORECTAL CANCER

Amanda Cuddy¹, Lisa M. Lowenstein, PhD, MPH¹, Andrea P. Hempstead¹, Vincent F. Richards¹, Katherine Van Loon², Y. Nancy You¹, Robert J. Volk, PhD¹ and George Chang¹, (1)The University of Texas MD Anderson Cancer Center, Houston, TX, (2)University of California San Francisco, San Francisco, CA

PS 3-32

PERSONALIZED RADIOTHERAPY IN HPV+ OROPHARYNGEAL CANCER

Wade P Smith, PhD¹, John H Gennari, Ph.D.², Upendra Parvathenini, MD¹, Jay Liao, MD¹ and Mark H. Phillips, Ph.D.¹, (1)Department of Radiation Oncology, University of Washington, Seattle, WA, (2)Department of Biomedical Informatics and Health Education, University of Washington, Seattle, WA

PS 3-33

DECISION FOR NON-COMPLETION OF FOLLOWUP AMONG PATIENTS WITH ABNORMAL SCREENING TEST FOR HEREDITARY COLORECTAL CANCER SYNDROME

Sameer Patel, MD¹, George Chang², Amanda Cuddy², Maureen Mork¹, Sarah Bannon¹, Michael Egger¹, Ashley Holder¹, Brian Bednarski¹, John Skibber¹, Eduardo Vilar¹, Patrick Lynch¹, Miguel Rodriguez Bigas¹ and Y. Nancy You², (1)Houston, TX, (2)The University of Texas MD Anderson Cancer Center, Houston, TX

PS 3-34

A RANDOMIZED PILOT STUDY COMPARING THE EFFECTIVENESS OF TWO DECISION AIDS FOR STABLE CHEST DISCOMFORT

Liis Hinsberg, MA, Felisha Marques, MPH, Lauren Leavitt, MA, Karen R. Sepucha, PhD and Jason Wasfy, MD, MPhil, Massachusetts General Hospital, Boston, MA

PS 3-35

CORE VALUE INFLUENCES ON ADVANCED DIRECTIVE DECISION MAKING IN JAPAN

John Friend, PhD, College of St. Benedict St. John's University, Collegeville, MN, Masahito Jimbo, MD, PhD, MPH, University of Michigan, Ann Arbor, MI, Yasunari Ogiso, MD, PhD, Keimeikai Clinic, Aichi, Japan and Dana Alden, MA, MBA, PhD, University of Hawaii, Honolulu, HI

PS 3-36

RESULTS OF A PILOT STUDY OF A TAILORED SYMPTOM ASSESSMENT TOOL TO ENHANCE PATIENT-CENTERED CARE IN RHEUMATOID ARTHRITIS: CHOICE RA

Jennifer Barton, MD¹, Gina Evans-Young², Laura Trupin, MPH², Allison Schue, BS¹, Cornelia Ruland, RN, PhD, FACMI³ and Edward Yelin, PhD², (1)VA Portland Health Care System, Portland, OR, (2)UCSF, San Francisco, CA, (3)Center for Shared Desision Making and Collaborative Care Research, Oslo, Norway

PS 3-37

EVALUATING THE POTENTIAL PERFORMANCE GAIN END-USERS COULD ACHIEVE IN DIFFERENTIATING TRANSIENT ISCHEMIC ATTACK (TIA) OR MILD STROKE FROM NON-ISCHEMIC MIMIC CONDITIONS THROUGH USE OF A CLINICAL DECISION SUPPORT RULE

Maximilian Bibok, PhD¹, Kristine Votova, PhD², Colin Sedgwick, BSc³, Keely Hammond, BSc³, Serenity Aberdour, ND³, Jaclyn Morrison, MSc¹ and Andrew Penn, MD³, (1)Island Health Authority, Victoria, BC, Canada, (2)Victoria, BC, Canada, (3)University of British Columbia-Island Medical Program, Victoria, BC, Canada

PS 3-38

DEVELOPMENT AND BETA-TEST OF A CHRONIC LYMPHOCYTIC LEUKEMIA PATIENT DECISION AID

Thomas Leblanc, MD¹, David Rizzieri, MD¹, Robert Wolf, PharmD², Ellen Neylon, MSN³, Valerie Mayorga, PharmD⁴, Katie Deering, PharmD⁴ and Brad Schenkel, MS⁵, (1)Duke University Medical Center, Durham, NC, (2)Mayo Clinic, Rochester, MN, (3)Columbia University Medical Center, New York, NY, (4)EPI-Q, Inc., Oak Brook, IL, (5)Janssen Scientific Affairs, LLC, Horsham, PA

PS 3-39

VALUE JUDGMENTS AND TRADEOFFS IN CHOOSING QUANTITATIVE INFORMATION AND FRAMING FOR A DECISION AID

Peter H. Schwartz, MD, PhD¹, Karen K. Schmidt, MSN¹, Paul F. Muriello, BA¹, Thomas Imperiale, MD¹, Susan M. Perkins, PhD¹ and Susan M. Rawl, PhD², (1)Indiana University School of Medicine, Indianapolis, IN, (2)Indiana University School of Nursing, Indianapolis, IN

PS 3-40

A NOVEL METHOD TO ADDRESS UNCERTAINTY WITHIN A FERTILITY PRESERVATION DECISION AID

Laura A. Covarrubias, MSPH¹, Aakrati Mathur², Jaimin Shah, MD³, Andrea Bradford, PhD¹, Robert J. Volk, PhD¹ and Terri L. Woodard, MD¹, (1)The University of Texas MD Anderson Cancer Center, Houston, TX, (2)Portland State University, Portland, OR, (3)The University of Texas Medical School at Houston, Houston, TX

PS 3-42

THE NATURAL HISTORY OF PRESCRIPTION-OPIOID AND HEROIN EPIDEMIC IN THE US

Hawre Jalal, MD, PhD¹, Mark S. Roberts, MD, MPH² and Don Burke, MD¹, (1)University of Pittsburgh, Pittsburgh, PA, (2)University of Pittsburgh School of Medicine, Pittsburgh, PA

PS 3-43

THE RELATIVE IMPACTS OF ANTIRETROVIRAL THERAPY AND HARM REDUCTION INITIATIVES ON HIV INCIDENCE IN BRITISH COLUMBIA, CANADA: 1996-2013

Bohdan Nosyk, PhD¹, Xiao Zang, M.S.², Jeong Eun Min, MSc³, Emanuel Krebs, M.A.³, Viviane Lima, PhD³, M-J Milloy, PhD⁴, Jeannie Shoveller, PhD⁵, Rolando Barrios, MD³, Richard Harrigan, PhD⁴, Thomas Kerr, PhD⁶, Evan Wood, MD, PhD⁴ and Julio Montaner, MD⁷, (1)Simon Fraser University - Faculty of Health Sciences, Vancouver, BC, Canada, (2)British Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada, (3)BC Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada, (4)Division of AIDS, Faculty of Medicine, University of British Columbia; BC Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada, (5)School of Population and Public Health, University of British Columbia; BC Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada, (6)School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada, (7)Division of AIDS, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada

PS 3-44

EFFECT OF A PUBLIC SMOKING BAN ON PATTERNS OF SMOKING BEHAVIOR IN THE REPUBLIC OF IRELAND AND NORTHERN IRELAND

Adam Raymakers, MSc and Ciaran O'Neill, PhD, National University of Ireland, Galway, Ireland

PS 3-45

EPIDEMIOLOGIC PARAMETERS OF WEST NILE VIRUS INFECTIONS IN HUMANS: A SCOPING REVIEW

Man Wah Yeung¹, Emily Shing², Mark Nelder, PhD² and Beate Sander, PhD³, (1)Health Quality Ontario, Toronto, ON, Canada, (2)Public Health Ontario, Toronto, ON, Canada, (3)University of Toronto, Toronto, ON, Canada

PS 3-46

A QUALITATIVE STUDY OF THE PRODUCT FEATURES IMPORTANT TO ADULT CONSUMERS' USE OF ELECTRONIC NICOTINE DELIVERY SYSTEMS

Christine E. Kistler, MD, MASc¹, Micah L. Berman, JD², Trisha Crutchfield, MHA, MSIS³, Erin L. Sutfin, PhD⁴, Gary A. Zarkin, PhD⁵, Leah M. Ranney, PhD¹ and Adam O. Goldstein, MD, MPH¹, (1)Department of Family Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, (2)The Ohio State University, Columbus, OH, (3)UNC Center for Health Promotion and DIsease Prevention, The University of North Carolina at Chapel Hill, Chapel Hill, NC, (4)Wake Forest School of Medicine, Winston-Salem, NC, (5)RTI International, Durham, NC

PS 3-47

SMOKERS' UNEXPECTED COMMENTS ON CIGARETTE ADDITIVES DURING FOCUS GROUPS EXAMINING BELIEFS ABOUT SMOKING AND GENETICS

Erika A. Waters, PhD, MPH, Washington University School of Medicine, Saint Louis, MO and Sydney Philpott, BS, Washington University School of Medicine, St. Louis, MO

PS 3-48

AN ANALYSIS OF INFECTIOUS DISEASE SPREAD AND PREVENTION BASED ON MICROSCOPIC STRUCTURE OF SCHOOL POPULATION: ‘BACK MONTE CARLO' DATA APPROACH

Masayuki Kakehashi, PhD, Hiroshima University, Hiroshima, Japan and Shoko Kawano, PhD, Kurume University, Kurume, Japan

PS 3-49

DEVELOPMENT OF A NATURAL HISTORY MODEL OF WEST NILE VIRUS INFECTIONS IN HUMANS

Man Wah Yeung¹, Emily Shing², Mark Loeb³, David Naimark, MD, MSc, BSc⁴, Doug Sider², Huaiping Zhu⁵ and Beate Sander, PhD², (1)Health Quality Ontario, Toronto, ON, Canada, (2)Public Health Ontario, Toronto, ON, Canada, (3)McMaster University, Hamilton, ON, Canada, (4)University of Toronto, Toronto, ON, Canada, (5)York University, Toronto, ON, Canada

PS 3-50

IS THERE EVIDENCE FOR CONCORDANCE BETWEEN PATIENT AND PHYSICIANS FOR ASPECTS OF TREATMENTS THAT MATTER MOST? EVIDENCE FROM A REVIEW OF DISCRETE CHOICE EXPERIMENTS

Mark Harrison, PhD, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada, Katherine Milbers, Centre for Health Evaluation and Outcomes Sciences, Vancouver, BC, Canada, Marie Hudson, Jewish General Hospital and Lady David Research Institute, Montreal, QC, Canada and Nick Bansback, PhD, University of British Columbia; Centre for Clinical Epidemiology and Evaluation; Centre for Health Evaluation and Outcome Sciences, Vancouver, BC, Canada

PS 3-52

USING THE CHOICE SEQUENCE IN TIME TRADE-OFF AS DISCRETE CHOICES - DO THE TWO STORIES MATCH?

Liv Ariane Augestad, MD, PhD¹, Kim Rand-Hendriksen, PhD, Cand.Psychol¹ and Mathias Barra, PhD², (1)University of Oslo, Oslo, Norway, (2)Health Services Research Centre, Akershus University Hospital, Loerenskog, Norway

PS 3-53

DOES DIRECT TO CONSUMER ADVERTISING CHANGE CONSUMER CHOICES ABOUT PHARMACY ONLY MEDICINES? EVIDENCE FROM A DISCRETE CHOICE EXPERIMENT

Rosalie C. Viney, PhD¹, Stephen Goodall, MSc PhD², Deborah Street, PhD³ and Feili Zhao, PhD², (1)University of Technology, Sydney, Sydney, Australia, (2)University of Technology Sydney Centre for Health Economics Research and Evaluation, Sydney, Australia, (3)University of Technology Sydney, School of Mathematical and Physical Sciences, Sydney, Australia

PS 3-54

LIVING WITH ALLERGIES STUDY: AN EXPLORATORY STUDY TO UNDERSTAND ADULT PATIENT EXPERIENCES, ADHERENCE BARRIERS AND PREFERENCES RELATED TO TREATMENTS FOR ALLERGIC RHINOCONJUNCTIVITIS

Ellyn Charap¹, Jeff Brodscholl, Ph.D.¹, Brian Stone, MD², Heather L. Black, Ph.D.³ and Kim Heithoff, ScD⁴, (1)Adheris Behavioral Insights, inVentiv Health, Newtown, PA, (2)Allergy Partners of San Diego, San Diego, CA, (3)Merck Sharp & Dohme Corp., North Wales, PA, (4)Merck Sharp & Dohme Corp., Lebanon, NJ

PS 3-55

WEIGHTING OF AHI SCORES AND SYMPTOMS IN THE DIAGNOSIS OF SLEEP APNEA BY SLEEP SPECIALISTS

Nicholas Mitsakakis, MSc PhD¹, Lusine Abrahamyan, MD, MPH, PhD¹, Valeria E. Rac, MD, PhD¹, Suzanne Chung, BEd, CCRP², Petros Pechlivanoglou, MSc, PhD³, Michael Fitzpatrick, MB, BCh, DCH, FRCPI, MD, FRCPC, FAASM⁴ and Murray Krahn, MD, MSc, FRCPC¹, (1)Toronto Health Economics and Technology Assessment (THETA) Collaborative, Toronto, ON, Canada, (2)Toronto Health Economics and Technology Assessment (THETA) Collaborative, University of Toronto, Toronto, ON, Canada, (3)Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, ON, Canada, (4)Sleep Disorder Clinic, Kingston General Hospital, Queen’s University, Kingston, ON, Canada

PS 3-56

PATIENT PREFERENCES FOR GENOMICS-BASED INDIVIDUALIZED HEALTHCARE: DEVELOPMENT OF A DISCRETE CHOICE EXPERIMENT INSTRUMENT ON PRECISION MEDICINE

Josh Carlson, MPH, PhD¹, Simrun Grewal, MHS¹, William Canestaro, MSc¹, David Veenstra, PharmD, PhD¹, Anirban Basu, PhD¹ and Dean A. Regier, PhD², (1)Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, WA, (2)School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada

PS 3-57

VALIDATION AND INTEGRATION OF A PREDICTIVE WARNING SYSTEM COMBINING PHYSIOLOGICAL MEASURES AND BEDSIDE EVALUATIONS

Muge Capan, PhD, Stephen Hoover, MS, Justin Glasgow, MD, Susan Mascioli, MS, BSN, RN, CPHQ, NEA-BC and Eric V. Jackson, Jr., MD, MBA, Christiana Care Health System, Newark, DE

PS 3-58

IMPROVING NUMERACY IMPROVES HEALTH BEHAVIORS

Ellen Peters, PhD, Brittany Shoots-Reinhard, PhD, Mary Kate Tompkins, MA, Dan Schley, PhD, Louise Meilleur, MA, MPH, Aleksander Sinayev, MA, Martin Tusler, MS, Laura Wagner, PhD and Jennifer Crocker, PhD, Ohio State University, Columbus, OH

PS 3-59

THE DEVELOPMENT, CALIBRATION, AND VALIDATION OF THE US POPULATION HEALTH MICROSIMULATION MODEL

Natalia Olchanski, MS¹, Aaron Winn, MPP² and Yue Zhong, PhD¹, (1)Tufts Medical Center, Boston, MA, (2)University of North Carolina at Chapel Hill, Chapel Hill, NC

PS 3-60

ANALYZING POPULATION PROGRESSION DYNAMICS OF DEPRESSION FROM ELECTRONIC HEALTH RECORD USING A FAMILY OF MARKOV MODELS

Jiaqi Huang, MS, University of Washington, Seattle, WA and Shan Liu, PhD, Industrial and Systems Engineering, University of Washington, Seattle, WA

38th Annual North American Meeting of the Society for Medical Decision Making

October 23 - 26, 2016

Menu

POSTER SESSION III & CONTINENTAL BREAKFAST